Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-08 3:58 pm Purchase | 13G | MorphoSys AG MOR | Kynam Capital Management LP | 4,190,331 11.13% | 500,000 (+13.55%) | View |
| 2024-02-14 12:53 pm Sale | 13G | OLEMA PHARMACEUTICALS INC OLMA | Kynam Capital Management LP | 0 0% | -2,025,234 (Position Closed) | View |
| 2024-02-14 12:52 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | Kynam Capital Management LP | 3,005,904 5.5% | 3,005,904 (New Position) | View |
| 2024-02-14 12:51 pm Purchase | 13G | Cogent Biosciences Inc. COGT | Kynam Capital Management LP | 5,854,766 6.8% | 5,854,766 (New Position) | View |
| 2024-02-14 12:50 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Kynam Capital Management LP | 5,660,000 6.67% | 5,660,000 (New Position) | View |
| 2024-02-14 12:49 pm Purchase | 13G | Vera Therapeutics Inc. VERA | Kynam Capital Management LP | 3,650,339 8.22% | 2,241,241 (+159.06%) | View |
| 2024-02-14 12:47 pm Purchase | 13G | MorphoSys AG MOR | Kynam Capital Management LP | 3,690,331 9.8% | 3,690,331 (New Position) | View |
| 2024-02-14 12:45 pm Unchanged | 13G | BURNING ROCK BIOTECH LTD SPONS BNR | Kynam Capital Management LP | 8,694,426 10.19% | 0 (Unchanged) | View |
| 2024-01-10 4:08 pm Purchase | 13G | BURNING ROCK BIOTECH LTD SPONS BNR | Kynam Capital Management LP | 8,694,426 10.19% | 1,302,845 (+17.63%) | View |
| 2023-09-06 4:54 pm Purchase | 13G | 2SEVENTY BIO INC TSVT | Kynam Capital Management LP | 5,953,825 11.7% | 5,953,825 (New Position) | View |
| 2023-03-21 5:40 pm Sale | 13G | OLEMA PHARMACEUTICALS INC OLMA | Kynam Capital Management LP | 2,025,234 5% | -38,398,598 (-94.99%) | View |
| 2023-02-13 09:25 am Unchanged | 13G | CONCERT PHARMACEUTICALS INC. CNCE | Kynam Capital Management LP | 4,420,349 9.2% | 0 (Unchanged) | View |
| 2023-02-10 3:51 pm Purchase | 13G | CONCERT PHARMACEUTICALS INC. CNCE | Kynam Capital Management LP | 4,420,349 9.2% | 4,420,349 (New Position) | View |
| 2023-02-10 1:20 pm Purchase | 13G | Vera Therapeutics Inc. VERA | Kynam Capital Management LP | 1,409,098 5.1% | 1,409,098 (New Position) | View |
| 2023-02-10 1:18 pm Purchase | 13G | OLEMA PHARMACEUTICALS INC OLMA | Kynam Capital Management LP | 40,423,832 5% | 40,423,832 (New Position) | View |
| 2023-02-10 1:16 pm Purchase | 13G | BURNING ROCK BIOTECH LTD SPONS BNR | Kynam Capital Management LP | 7,391,581 8.4% | 7,391,581 (New Position) | View |